These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38442796

  • 1. Co-release of paclitaxel and encequidar from amorphous solid dispersions increase oral paclitaxel bioavailability in rats.
    Petersen EF, Larsen BS, Nielsen RB, Pijpers I, Versweyveld D, Holm R, Tho I, Snoeys J, Nielsen CU.
    Int J Pharm; 2024 Apr 10; 654():123965. PubMed ID: 38442796
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB, Lodagekar A, Yadav B, Shastri NR.
    Drug Deliv Transl Res; 2020 Aug 10; 10(4):903-918. PubMed ID: 32378174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.
    Hirai D, Tsunematsu H, Kimura SI, Itai S, Fukami T, Iwao Y.
    Int J Pharm; 2022 Sep 25; 625():122110. PubMed ID: 35970282
    [Abstract] [Full Text] [Related]

  • 6. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X, Xu T, Huang W, Fan B, Sheng X.
    AAPS PharmSciTech; 2019 Mar 18; 20(4):143. PubMed ID: 30887265
    [Abstract] [Full Text] [Related]

  • 7. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM, Nguyen JH, Becker C, Francke NM, Jørgensen EB, Holm P, Holm R, Mu H, Rades T, Langguth P.
    Eur J Pharm Biopharm; 2016 Apr 18; 101():145-51. PubMed ID: 26899127
    [Abstract] [Full Text] [Related]

  • 8. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M, Wu C, Fu Q, Di D, Kuang X, Wang C, He Z, Wang J, Sun J.
    Int J Pharm; 2016 Apr 30; 503(1-2):238-46. PubMed ID: 26869398
    [Abstract] [Full Text] [Related]

  • 9. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
    Xu WJ, Xie HJ, Cao QR, Shi LL, Cao Y, Zhu XY, Cui JH.
    Drug Deliv; 2016 Apr 30; 23(1):41-8. PubMed ID: 24735247
    [Abstract] [Full Text] [Related]

  • 10. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM, Wendelboe J, Holm R, Rades T.
    Eur J Pharm Biopharm; 2018 Sep 30; 130():290-295. PubMed ID: 30064702
    [Abstract] [Full Text] [Related]

  • 11. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
    Fan N, Lu T, Li J.
    J Pharm Sci; 2020 Feb 30; 109(2):1068-1078. PubMed ID: 31639390
    [Abstract] [Full Text] [Related]

  • 12. Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.
    Saboo S, Moseson DE, Kestur US, Taylor LS.
    Eur J Pharm Sci; 2020 Dec 01; 155():105514. PubMed ID: 32810579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of polymer type and drug dose on the in vitro and in vivo behavior of amorphous solid dispersions.
    Knopp MM, Chourak N, Khan F, Wendelboe J, Langguth P, Rades T, Holm R.
    Eur J Pharm Biopharm; 2016 Aug 01; 105():106-14. PubMed ID: 27212472
    [Abstract] [Full Text] [Related]

  • 15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 01; 41(4):413-22. PubMed ID: 25669445
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GGZ, Taylor LS.
    J Pharm Sci; 2011 Aug 01; 100(8):3316-3331. PubMed ID: 21607951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
    Liu L, Chen L, Müllers W, Serno P, Qian F.
    Mol Pharm; 2022 Aug 01; 19(8):2888-2899. PubMed ID: 35759395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.